Halozyme Therapeutics Inc
(NAS:HALO)
$
74.96
+2.32 (+3.19%)
Market Cap: 8.89 Bil
Enterprise Value: 10.72 Bil
PE Ratio: 26.96
PB Ratio: 40.45
GF Score: 92/100 Halozyme Therapeutics Inc (HALO) Transcripts
- 1